Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
02 August 2013
Header
Header image
Highlight of the week

From our blog

Keeping the Conversation Going on Data Sharing Commitments
02 August 2013 by Richard Bergström

I have spent much time over the past week speaking with journalists, fellow industry professionals, and other interested parties about the EFPIA-PhRMA joint commitments to [...] Read more

From our blog

From our blog

“Dreadful” Access to Medicines – A Topic Not to Be Ignored
01 August 2013 by Richard Bergström

In an interview published last week, Paweł Sztwiertnia, Director General of Poland’s INFARMA – an EFPIA member company – discussed the state of the innovative [...] Read more

From our blog

Taking Governance for Granted
01 August 2013 by Richard Bergström

Living in Western Europe, largely free from corruption, it is difficult to imagine what happens to society if there is no good governance. Imagine that [...] Read more

Videos

Video

Clinical Trials and Transparency

Clinical Trials and Transparency voiced by EFPIA Director General Richard Bergström

View video

What we are reading

What we are reading

'Engineered mice act as hepatitis C model'
02 August 2013 (Nature)

One piece of news that caught our attention this week was the report that researchers have created a strain of mouse that is "completely vulnerable" to Hepatitis C. Mice are naturally immune to Hepatitis C -- so the development could help in efforts towards a vaccine. You can read the report in Nature

 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail